ConvaVAC™ Ag+ Negative Pressure Wound Therapy System in Chronic Wounds
NCT: NCT07342049 · RECRUITING
Brief Summary
Purpose of this study is to learn more about how safe and effective the ConvaVAC™ Ag+ wound therapy system is in treating certain types of long-lasting wounds, called chronic wounds. In this study, the focus is on Venous Leg Ulcers (VLUs). Chronic wounds are wounds that do not heal properly or take a long time to heal. They can cause pain, discomfort, and affect your day-to-day life. These types of wounds are also challenging for healthcare teams to treat and can take up a lot of healthcare resources. Venous Leg Ulcers (VLUs) are the most common type of chronic leg wound and affect about 1 in every 100 people. Usual treatments for VLUs include cleaning the wound, using special dressings, applying pressure (compression therapy), and sometimes using creams or dressings that contain silver to fight infection. This study is being done to see if the wound therapy system can help heal venous leg ulcers more effectively and safely.
Frequently Asked Questions
What is ConvaVAC™ Ag+ Negative Pressure Wound Therapy System in Chronic Wounds?
ConvaVAC™ Ag+ Negative Pressure Wound Therapy System in Chronic Wounds is a clinical trial registered under NCT07342049. Current status: RECRUITING.
What is the status of NCT07342049?
The current status of NCT07342049 (ConvaVAC™ Ag+ Negative Pressure Wound Therapy System in Chronic Wounds) is: RECRUITING.
When did ConvaVAC™ Ag+ Negative Pressure Wound Therapy System in Chronic Wounds start?
ConvaVAC™ Ag+ Negative Pressure Wound Therapy System in Chronic Wounds started on 2026-01-12.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.